Express Pharma
Express Pharma
Browsing tag
higher-risk myelodysplastic syndromes
US FDA places partial clinical hold on Gilead’s studies on Magrolimab for AML treatment
Read more
US FDA grants Breakthrough Therapy Designation for Takeda’s Pevonedistat
Read more